Loading clinical trials...
Loading clinical trials...
This study is a multicenter, double blinded, active and placebo controlled randomized clinical trial to demonstrate a superior lipid lowering effect of Bococizumab (PF-04950615; RN316) compared to pla...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT06451770 · Hypercholesterolemia, Hypertriglyceridemia, and more
NCT07473960 · Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
NCT06062394 · Hypertension, Hyperlipidemias
NCT07230730 · Hyperlipidemia
NCT07334834 · Hyperlipidemia
Creekside Endocrine Associates, PC
Denver, Colorado
Bridgeport Hospital
Bridgeport, Connecticut
Watson Clinic Center for Research, Inc. (for Drug Shipment only)
Lakeland, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions